A Comparison of Clinical Characteristics in Overweight/Obese and Normal Weight Patients with Psoriasis Vulgaris: A Bicentric Retrospective Observational Study

References

• Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/S0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• Yamazaki F. Psoriasis: comorbidities. J Dermatol. 2021;48(6):732–740. doi:10.1111/1346-8138.15840
   PubMed Web of Science ®Google Scholar
• Snekvik I, Smith CH, Nilsen TIL, et al. Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study. J Invest Dermatol. 2017;137(12):2484–2490. doi:10.1016/j.jid.2017.07.822
   PubMed Web of Science ®Google Scholar
• Budu-Aggrey A, Brumpton B, Tyrrell J, et al. Evidence of a causal relationship between body mass index and psoriasis: a Mendelian randomization study. PLoS Med. 2019;16(1):e1002739. doi:10.1371/journal.pmed.1002739
   PubMed Web of Science ®Google Scholar
• Norden A, Rekhtman S, Strunk A, Garg A. Risk of psoriasis according to body mass index: a retrospective cohort analysis. J Am Acad Dermatol. 2022;86(5):1020–1026. doi:10.1016/j.jaad.2021.06.012
   PubMed Web of Science ®Google Scholar
• Hung YT, Lin YJ, Chiu HY, Huang YH. Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice. Ther Adv Chronic Dis. 2021;12:20406223211046685. doi:10.1177/20406223211046685
   Web of Science ®Google Scholar
• Shan J, Zhang J. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis. Joint Bone Spine. 2019;86(2):173–183. doi:10.1016/j.jbspin.2018.03.007
   PubMed Web of Science ®Google Scholar
• Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451–485. doi:10.1016/j.jaad.2009.03.027
   PubMed Web of Science ®Google Scholar
• Mahil SK, McSweeney SM, Kloczko E, McGowan B, Barker JN, Smith CH. Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic. Br J Dermatol. 2019;181(5):946–953. doi:10.1111/bjd.17741
   PubMed Web of Science ®Google Scholar
• Jensen P, Skov L. Psoriasis and obesity. Dermatology. 2016;232(6):633–639. doi:10.1159/000455840
   PubMed Web of Science ®Google Scholar
• Polo TCF, Corrente JE, Miot LDB, Papini SJ, Miot HA. Dietary patterns of patients with psoriasis at a public healthcare institution in Brazil. An Bras Dermatol. 2020;95(4):452–458. doi:10.1016/j.abd.2020.02.002
   PubMed Web of Science ®Google Scholar
• Paroutoglou K, Papadavid E, Christodoulatos GS, Dalamaga M. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations. Curr Obes Rep. 2020;9(3):165–178. doi:10.1007/s13679-020-00380-3
   PubMed Web of Science ®Google Scholar
• Kaushik SB, Lebwohl MG. Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol. 2019;80(1):27–40. doi:10.1016/j.jaad.2018.06.057
   PubMed Web of Science ®Google Scholar
• Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses’ health study II. Arch Intern Med. 2007;167(15):1670–1675. doi:10.1001/archinte.167.15.1670
   PubMed Web of Science ®Google Scholar
• Barros G, Duran P, Vera I, Bermúdez V. Exploring the links between obesity and psoriasis: a comprehensive review. Int J Mol Sci. 2022;23(14):7499. doi:10.3390/ijms23147499
   PubMed Web of Science ®Google Scholar
• Jaacks LM, Vandevijvere S, Pan A, et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 2019;7(3):231–240. doi:10.1016/S2213-8587(19
   PubMed Web of Science ®Google Scholar
• Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752–1770. doi:10.1161/CIRCRESAHA.115.306883
   PubMed Web of Science ®Google Scholar
• Chen C, Lu FC. Department of disease control ministry of health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1–36.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2(12):e54. doi:10.1038/nutd.2012.26
   PubMed Web of Science ®Google Scholar
• Han JH, Lee JH, Han KD, et al. Increased risk of psoriasis in subjects with abdominal obesity: a nationwide population-based study. J Dermatol. 2019;46(8):695–701. doi:10.1111/1346-8138.14939
   PubMed Web of Science ®Google Scholar
• Chehimi M, Vidal H, Eljaafari A. Pathogenic role of IL-17-producing immune cells in obesity, and related inflammatory diseases. J Clin Med. 2017;6(7):68. doi:10.3390/jcm6070068
   PubMed Web of Science ®Google Scholar
• Nakamizo S, Honda T, Adachi A, et al. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells. Sci Rep. 2017;7(1):14076. doi:10.1038/s41598-017-14292-1
   PubMed Web of Science ®Google Scholar
• Pestel J, Chehimi M, Bonhomme M, Robert M, Vidal H, Eljaafari A. IL-17A contributes to propagation of inflammation but does not impair adipogenesis and/or insulin response, in adipose tissue of obese individuals. Cytokine. 2020;126:154865. doi:10.1016/j.cyto.2019.154865
   PubMed Web of Science ®Google Scholar
• Chehimi M, Robert M, Bechwaty ME, et al. Adipocytes, like their progenitors, contribute to inflammation of adipose tissues through promotion of Th-17 cells and activation of monocytes, in obese subjects. Adipocyte. 2016;5(3):275–282. doi:10.1080/21623945.2015.1134402
   PubMed Web of Science ®Google Scholar
• Qi Y, Liu W, Wang X, et al. Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia. Stem Cell Res Ther. 2021;12(1):277. doi:10.1186/s13287-021-02357-y
   PubMedGoogle Scholar
• Ko SH, Chi CC, Yeh ML, Wang SH, Tsai YS, Hsu MY. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019;7(7):CD011972. doi:10.1002/14651858.CD011972.pub2
   PubMed Web of Science ®Google Scholar
• Lynch M, Ahern T, Sweeney CM, et al. Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction. Int J Dermatol. 2017;56(11):1103–1118. doi:10.1111/ijd.13699
   PubMed Web of Science ®Google Scholar
• Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981–1000. doi:10.1016/j.autrev.2014.07.001
   PubMed Web of Science ®Google Scholar
• Tadokoro S, Ide S, Tokuyama R, et al. Leptin promotes wound healing in the skin. PLoS One. 2015;10(3):e0121242. doi:10.1371/journal.pone.0121242
   PubMed Web of Science ®Google Scholar
• Zhu KJ, Zhang C, Li M, Zhu CY, Shi G, Fan YM. Leptin levels in patients with psoriasis: a meta-analysis. Clin Exp Dermatol. 2013;38(5):478–483. doi:10.1111/ced.12171
   PubMed Web of Science ®Google Scholar
• Xue K, Liu H, Jian Q, et al. Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro--a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol. 2013;22(6):406–410. doi:10.1111/exd.12162
   PubMed Web of Science ®Google Scholar
• Okan G, Baki AM, Yorulmaz E, Doğru-Abbasoğlu S, Vural P. Serum visfatin, fetuin-A, and pentraxin 3 levels in patients with psoriasis and their relation to disease severity. J Clin Lab Anal. 2016;30(4):284–289. doi:10.1002/jcla.21850
   PubMed Web of Science ®Google Scholar
• Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S, Watanabe S. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology. 2011;152(8):3155–3164. doi:10.1210/en.2010-1481
   PubMed Web of Science ®Google Scholar
• Shibata S, Saeki H, Tada Y, Karakawa M, Komine M, Tamaki K. Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci. 2009;55(1):62–63. doi:10.1016/j.jdermsci.2009.02.009
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100. doi:10.1093/jmcb/mjw011
   PubMed Web of Science ®Google Scholar
• Ma C, Harskamp CT, Armstrong EJ, Armstrong AW. The association between psoriasis and dyslipidaemia: a systematic review. Br J Dermatol. 2013;168(3):486–495. doi:10.1111/bjd.12101
   PubMed Web of Science ®Google Scholar
• Xiao Y, Jing D, Tang Z, et al. Serum lipids and risk of incident psoriasis: a prospective cohort study from the UK biobank study and Mendelian randomization analysis. J Invest Dermatol. 2022;142(12):3192–3199.e12. doi:10.1016/j.jid.2022.06.015
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196–4200. doi:10.1210/jcem.82.12.4450
   PubMed Web of Science ®Google Scholar
• Widawski L, Fabacher T, Spielmann L, et al. Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat. Clin Rheumatol. 2022;41(5):1421–1429. doi:10.1007/s10067-022-06061-x
   PubMed Web of Science ®Google Scholar
• Zhao Z, Cai L, Zhang S, et al. Effects of secukinumab and Adalimumab on serum uric acid level in patients with plaque psoriasis. Chin Med J. 2022;135(12):1438–1443. doi:10.1097/CM9.0000000000002130
   PubMed Web of Science ®Google Scholar
• Wang J, Chen S, Zhao J, et al. Association between nutrient patterns and hyperuricemia: mediation analysis involving obesity indicators in the NHANES. BMC Public Health. 2022;22(1):1981. doi:10.1186/s12889-022-14357-5
   PubMed Web of Science ®Google Scholar
• Bellinato F, Gisondi P, Mantovani A, Girolomoni G, Targher G. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies. J Endocrinol Invest. 2022;45(7):1277–1288. doi:10.1007/s40618-022-01755-0
   PubMed Web of Science ®Google Scholar
• Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015;40(7):722–727. doi:10.1111/ced.12672
   PubMed Web of Science ®Google Scholar
• Shao S, He F, Yang Y, Yuan G, Zhang M, Yu X. Th17 cells in type 1 diabetes. Cell Immunol. 2012;280(1):16–21. doi:10.1016/j.cellimm.2012.11.001
   PubMed Web of Science ®Google Scholar
• Pérez-García A, Torrecilla-Parra M, Fernández-de Frutos M, Martín-Martín Y, Pardo-Marqués V, Ramírez CM. Posttranscriptional regulation of insulin resistance: implications for metabolic diseases. Biomolecules. 2022;12(2):208. doi:10.3390/biom12020208
   PubMed Web of Science ®Google Scholar
• Krakowiak J, Raczkiewicz D, Humeniuk E, Wdowiak A, Wróbel A, Bojar I. Metabolic syndrome, BMI, and polymorphism of estrogen receptor-α in peri- and post-menopausal Polish women. Metabolites. 2022;12(8):673. doi:10.3390/metabo12080673
   PubMed Web of Science ®Google Scholar
• Korovesi A, Dalamaga M, Kotopouli M, Papadavid E. Adherence to the Mediterranean diet is independently associated with psoriasis risk, severity, and quality of life: a cross-sectional observational study. Int J Dermatol. 2019;58(9):e164–e165. doi:10.1111/ijd.14523
   PubMed Web of Science ®Google Scholar
• Castaldo G, Rastrelli L, Galdo G, Molettieri P, Rotondi Aufiero F, Cereda E. Aggressive weight-loss program with a ketogenic induction phase for the treatment of chronic plaque psoriasis: a proof-of-concept, single-arm, open-label clinical trial. Nutrition. 2020;74:110757. doi:10.1016/j.nut.2020.110757
   PubMed Web of Science ®Google Scholar
• Donnelly JE, Blair SN, Jakicic JM, et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults [published correction appears in Med Sci Sports Exerc. 2009 Jul;41(7):1532]. Med Sci Sports Exerc. 2009;41(2):459–471. doi:10.1249/MSS.0b013e3181949333
   PubMed Web of Science ®Google Scholar
• Vella CA, Taylor K, Drummer D. High-intensity interval and moderate-intensity continuous training elicit similar enjoyment and adherence levels in overweight and obese adults. Eur J Sport Sci. 2017;17(9):1203–1211. doi:10.1080/17461391.2017.1359679
   PubMed Web of Science ®Google Scholar
• Johns DJ, Hartmann-Boyce J, Jebb SA, Aveyard P; Behavioural Weight Management Review Group. Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons. J Acad Nutr Diet. 2014;114(10):1557–1568. doi:10.1016/j.jand.2014.07.005
   PubMed Web of Science ®Google Scholar